367 related articles for article (PubMed ID: 806016)
1. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
Shapiro WR; Young DF; Mehta BM
N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
[TBL] [Abstract][Full Text] [Related]
2. Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.
Bacher JD; Balis FM; McCully CL; Godwin KS
Lab Anim Sci; 1994 Apr; 44(2):148-52. PubMed ID: 8028278
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.
Balis FM; Blaney SM; McCully CL; Bacher JD; Murphy RF; Poplack DG
Cancer Chemother Pharmacol; 2000; 45(3):259-64. PubMed ID: 10663645
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
Wang JJ; Freeman AI; Sinks LF
Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
8. [A case of cerebrospinal fluid hypovolemia caused by Ommaya reservoir successfully treated by epidural blood patch].
Jimbo Y; Uzuka T; Fujii Y
No Shinkei Geka; 2008 Jul; 36(7):639-43. PubMed ID: 18634407
[TBL] [Abstract][Full Text] [Related]
9. [Study of meningeal carcinomatosis: diagnosis and treatment].
Nakagawa H; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Kubo S; Hayakawa T
No Shinkei Geka; 1992 Jan; 20(1):31-7. PubMed ID: 1738424
[TBL] [Abstract][Full Text] [Related]
10. Treatment of meningeal neoplasms.
Shapiro WR; Posner JB; Ushio Y; Chemik NL; Young DF
Cancer Treat Rep; 1977 Jul; 61(4):733-43. PubMed ID: 577896
[No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
12. Direct administration of methotrexate into the central nervous system of primates. Part 2: Distribution of 3H methotrexate after intrathecal lumbar injection.
Yen J; Reiss FL; Kimelberg HK; Bourke RS
J Neurosurg; 1978 Jun; 48(6):895-902. PubMed ID: 96229
[TBL] [Abstract][Full Text] [Related]
13. Active transport of methotrexate from cerebrospinal fluid in humans.
Bode U; Magrath IT; Bleyer WA; Poplack DG; Glaubiger DL
Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786
[TBL] [Abstract][Full Text] [Related]
14. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
Blasberg RG; Patlak CS; Shapiro WR
Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
[No Abstract] [Full Text] [Related]
15. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.
Bleyer WA; Drake JC; Chabner BA
N Engl J Med; 1973 Oct; 289(15):770-3. PubMed ID: 4517004
[No Abstract] [Full Text] [Related]
17. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
18. Cerebral venous and sinus thrombosis with cerebrospinal fluid circulation block after the first methotrexate administration by lumbar puncture.
Bienfait HP; Gijtenbeek JM; van den Bent MJ; de Bruin HG; Voogt PJ; Pillay M
Neuroradiology; 2002 Nov; 44(11):929-32. PubMed ID: 12428129
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate. II. Use in pediatric chemotherapy.
Lippens RJ
Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
[TBL] [Abstract][Full Text] [Related]
20. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis.
Mehta BM; Glass JP; Shapiro WR
Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]